Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling

por Lebedev, Timofey, Buzdin, Anton, Khabusheva, Elmira, Spirin, Pavel, Suntsova, Maria, Sorokin, Maxim, Popenko, Vladimir, Rubtsov, Petr, Prassolov, Vladimir
Publicado 2022

Changes of lysosomes in the earliest stages of the development of atherosclerosis

por Bobryshev, Yuri V, Shchelkunova, Tatyana A, Morozov, Ivan A, Rubtsov, Petr M, Sobenin, Igor A, Orekhov, Alexander N, Smirnov, Alexander N
Publicado 2013

Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta

por Shchelkunova, Tatyana A., Morozov, Ivan A., Rubtsov, Petr M., Bobryshev, Yuri V., Sobenin, Igor A., Orekhov, Alexander N., Andrianova, Irina V., Smirnov, Alexander N.
Publicado 2013

Hepatitis Delta Virus Antigens Trigger Oxidative Stress, Activate Antioxidant Nrf2/ARE Pathway, and Induce Unfolded Protein Response

por Smirnova, Olga A., Ivanova, Olga N., Mukhtarov, Furkat, Valuev-Elliston, Vladimir T., Fedulov, Artemy P., Rubtsov, Petr M., Zakirova, Natalia F., Kochetkov, Sergey N., Bartosch, Birke, Ivanov, Alexander V.
Publicado 2023

Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes

por Lebedev, Timofey, Vagapova, Elmira, Spirin, Pavel, Rubtsov, Petr, Astashkova, Olga, Mikheeva, Alesya, Sorokin, Maxim, Vladimirova, Uliana, Suntsova, Maria, Konovalov, Dmitry, Roumiantsev, Alexander, Stocking, Carol, Buzdin, Anton, Prassolov, Vladimir
Publicado 2021

Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes

por Panova, Alexandra V., Klementieva, Natalia V., Sycheva, Anna V., Korobko, Elena V., Sosnovtseva, Anastasia O., Krasnova, Tatiana S., Karpova, Maria R., Rubtsov, Petr M., Tikhonovich, Yulia V., Tiulpakov, Anatoly N., Kiselev, Sergey L.
Publicado 2022

Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors

por Lebedev, Timofey D., Khabusheva, Elmira R., Mareeva, Sofia R., Ivanenko, Karina A., Morozov, Alexey V., Spirin, Pavel V., Rubtsov, Petr M., Snezhkina, Anastasiya V., Kudryavtseva, Anna V., Sorokin, Maxim I., Buzdin, Anton A., Prassolov, Vladimir S.
Publicado 2022